Trial of Decitabine in Patients With Acute Myeloid Leukemia
Public ClinicalTrials.gov record NCT00260832. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Phase 3 Trial of Decitabine Versus Patient's Choice With Physician's Advice of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the results in older patients who have newly diagnosed or secondary acute myeloid leukemia (AML) and who are to either receive decitabine or patient's choice with the physician's advice of either cytarabine or supportive care medication.
Study identification
- NCT ID
- NCT00260832
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 485 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2005 (Type not available)
- Primary completion
- Oct 2009 (Actual)
- Completion
- Dec 2010 (Actual)
- Last update posted
- Sep 11, 2019
2005 – 2010
United States locations
- U.S. sites
- 37
- U.S. states
- 19
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Los Angeles | California | — | — |
| Not listed | Fort Myers | Florida | 33901 | — |
| Not listed | Gainesville | Florida | 32610 | — |
| Not listed | Hollywood | Florida | — | — |
| Not listed | Lakeland | Florida | 33805 | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Orange Park | Florida | 32073 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Highland Park | Illinois | — | — |
| Not listed | Terre Haute | Indiana | 47804 | — |
| Not listed | Sioux City | Iowa | 51101 | — |
| Not listed | Wichita | Kansas | 67214 | — |
| Not listed | Baton Rouge | Louisiana | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Boston | Massachusetts | — | — |
| Not listed | Springfield | Massachusetts | 01107 | — |
| Not listed | Grosse Pointe Woods | Michigan | 48236 | — |
| Not listed | Kalamazoo | Michigan | 49048 | — |
| Not listed | Neptune City | New Jersey | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Valhalla | New York | 10595 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Not listed | Canton | Ohio | 44710 | — |
| Not listed | Cincinnati | Ohio | 45267 | — |
| Not listed | Pittsburgh | Pennsylvania | 15232 | — |
| Not listed | Charleston | South Carolina | 29406 | — |
| Not listed | Greenville | South Carolina | — | — |
| Not listed | Sioux Falls | South Dakota | 57105 | — |
| Not listed | Knoxville | Tennessee | 37920 | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Galveston | Texas | 77555 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Temple | Texas | — | — |
| Not listed | Eau Claire | Wisconsin | — | — |
| Not listed | Glendale | Wisconsin | 53212 | — |
| Not listed | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00260832, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 11, 2019 · Synced Nov 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00260832 live on ClinicalTrials.gov.